S. N. F. Rizvi (*) : A. van Lingen: O. S. Hoekstra:

Biodistribution, radiation dosimetry and scouting of 90 Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89 Zr-ibritumomab tiuxetan and PE